Newsletter | May 10, 2025

05.10.25 -- Clinical Leader Best Of April

APRIL'S BEST FEATURED EDITORIAL

Takeda's Diversity Strategy Pays Off For Phase 3 Trial

LaShell Robinson, head of global feasibility and trial equity at Takeda, explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. 

3 Generative AI Prompts To Strengthen Your SOPs Without Sacrificing Compliance

Discover three easy and customizable prompts to help support SOP development, refinement, and training — all areas where AI can add immediate value with minimal downside. 

Where Do We Stand With DCTs Heading Into 2025?

Clinical Leader asked familiar voices and new faces alike: “What’s left to say, to understand, or to do with DCTs (or elements thereof) in 2025?”

APRIL'S BEST INDUSTRY INSIGHTS

6 AI And Machine Learning Considerations For Trial Management

Are you considering integrating AI and ML into your workflow? These six considerations will help you plan out an effective trial.

The Digital Teammate: How AI Is Changing Clinical Research

AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

Navigating The Future Of Lab Developed Tests

Explore the pivotal role of lab-developed tests (LDTs) in medical diagnostics, their growing regulatory scrutiny, and their future trajectory in modern healthcare to advance patient care.

APRIL'S BEST SOLUTIONS

Streamline Electronic Data Capture With iMednet EDC

GxP Data Integrity: Assessment, Readiness, And Compliance

20/20 Onsite - Learn What We Do

Connect With Clinical Leader: